*Demar =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=*
via forma full 5 https://ift.tt/7KRzLSt Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571586.html)
via forma full 5 https://ift.tt/7KRzLSt Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571586.html)
Forma-Odezhda
Купить Товары Demar Купить
Купить Товары
История польской компании DEMAR началась в 1978 году. Предприятие занимается производством детской и взрослой обуви высокого качества. Динамично развиваясь, компания получила заслуженное признание и потребительские симпатии не только
История польской компании DEMAR началась в 1978 году. Предприятие занимается производством детской и взрослой обуви высокого качества. Динамично развиваясь, компания получила заслуженное признание и потребительские симпатии не только
Demar =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=
via forma full 5 https://ift.tt/7KRzLSt Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/7KRzLSt Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
Купить Товары Demar Купить
Купить Товары
История польской компании DEMAR началась в 1978 году. Предприятие занимается производством детской и взрослой обуви высокого качества. Динамично развиваясь, компания получила заслуженное признание и потребительские симпатии не только
История польской компании DEMAR началась в 1978 году. Предприятие занимается производством детской и взрослой обуви высокого качества. Динамично развиваясь, компания получила заслуженное признание и потребительские симпатии не только
*Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales*
Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/rite-aid-seeks-chapter-11-bankruptcy-amid-opioid-lawsuits-sliding-sales)
Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/rite-aid-seeks-chapter-11-bankruptcy-amid-opioid-lawsuits-sliding-sales)
TheStreet
Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales
Rite Aid hopes to continue operations through its Chapter 11 bankruptcy, but will close stores and cut costs amid slumping Covid sales and pending opioid lawsuits.
Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales
Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales
Rite Aid hopes to continue operations through its Chapter 11 bankruptcy, but will close stores and cut costs amid slumping Covid sales and pending opioid lawsuits.
*Как приготовить тыквенный латте как в «Старбаксе»*
Согревающий напиток со вкусом тыквенного пирога.
[Read more...](https://burninghut.ru/tykvennoe-latte/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=tykvennoe-latte)
Согревающий напиток со вкусом тыквенного пирога.
[Read more...](https://burninghut.ru/tykvennoe-latte/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=tykvennoe-latte)
*Xiaomi представила умный наматрасник с подогревом и режимом уничтожения клещей*
Вся электроника вынесена во внешний блок, поэтому бельё абсолютно безопасно (уверяет производитель).
[Read more...](https://lifehacker.ru/mijia-plumbing-blanket-anons/)
Вся электроника вынесена во внешний блок, поэтому бельё абсолютно безопасно (уверяет производитель).
[Read more...](https://lifehacker.ru/mijia-plumbing-blanket-anons/)
*Как заморозить опята на зиму: 3 лучших способа*
Грибы можно заготовить свежими, варёными или в виде фарша.
[Read more...](https://lifehacker.ru/kak-zamorozit-opyata/)
Грибы можно заготовить свежими, варёными или в виде фарша.
[Read more...](https://lifehacker.ru/kak-zamorozit-opyata/)
*7 основ безопасности в интернете, которыми мы часто пренебрегаем*
Эти простые действия защитят от неприятностей.
[Read more...](https://lifehacker.ru/bezopasnost-v-internete/)
Эти простые действия защитят от неприятностей.
[Read more...](https://lifehacker.ru/bezopasnost-v-internete/)
*We Asked 3 Pro Cleaners to Name the Best Sponge*
There was a clear winner. READ MORE...
[Read more...](https://www.apartmenttherapy.com/best-sponge-pro-cleaners-37325422?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
There was a clear winner. READ MORE...
[Read more...](https://www.apartmenttherapy.com/best-sponge-pro-cleaners-37325422?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*Stock Market Today: Stocks gain, oil edges higher as markets eye middle east tensions*
Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stock-market-today-stocks-steady-as-markets-eye-middle-east-tensions)
Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stock-market-today-stocks-steady-as-markets-eye-middle-east-tensions)
TheStreet
Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions
Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.
Stock Market Today: Stocks gain, oil edges higher as markets eye middle east tensions
Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
TheStreet
Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions
Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.
*Подкаст «Пульверизатор науки»: факты и мифы о динозаврах*
Рассказываем, как они выглядели и где жили. А также выясняем, умели ли летать, плавать и танцевать.
[Read more...](https://lifehacker.ru/pulverizator-nauki-3/)
Рассказываем, как они выглядели и где жили. А также выясняем, умели ли летать, плавать и танцевать.
[Read more...](https://lifehacker.ru/pulverizator-nauki-3/)
**
Detected change on http://feed.informer.com/widgets/W1BPKT0XMB: http://feed.informer.com/widgets/W1BPKT0XMB?diffydate=1697440136
[Read more...](https://mas.to/@analogindex/111244771830299495)
Detected change on http://feed.informer.com/widgets/W1BPKT0XMB: http://feed.informer.com/widgets/W1BPKT0XMB?diffydate=1697440136
[Read more...](https://mas.to/@analogindex/111244771830299495)
*Особенности*
via forma full 5 https://ift.tt/y4egEVS Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571321.html)
via forma full 5 https://ift.tt/y4egEVS Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3571321.html)
Forma-Odezhda
Особенности камуфляжа Цифра
Узнайте о Особенности камуфляжа Цифра в энциклопедии магазина Форма одежды.
Особенности
via forma full 5 https://ift.tt/y4egEVS Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
via forma full 5 https://ift.tt/y4egEVS Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
Forma-Odezhda
Особенности камуфляжа Цифра
Узнайте о Особенности камуфляжа Цифра в энциклопедии магазина Форма одежды.
*5 любимых десертов из детства, которые легко повторить дома*
Нашли для вас те самые орешки со сгущёнкой и шоколадную колбасу.
[Read more...](https://lifehacker.ru/deserty-iz-detstva/)
Нашли для вас те самые орешки со сгущёнкой и шоколадную колбасу.
[Read more...](https://lifehacker.ru/deserty-iz-detstva/)
*Are slim people lying about how much they eat or are they just blessed with a good metabolism?*
For a lot of my life I’ve been overweight, in the last few years I’ve lost weight but I’m definitely not slim, I’d say possibly midsize. I eat healthy and stay in suggested calories but really struggle to get to a slim weight. Are slim people lying about how much they eat and it’s an unspoken rule to eat a smaller amount or are they just blessed with a great metabolism? edits: I don’t drink my calories! I’m not a fan of really sugary drinks/coffee, even when I was at my biggest weight my coffee was black and I only really drink water. In terms of being active, I’ve walked 10,000 steps a day for the last few years. It was a promise I made to myself to keep it up and it’s something that I very rarely don’t do. The most common answer seems to be that fat people are lying to themselves which I believe somewhat to be true, I definitely was lying to myself at my biggest or maybe not even lying, just not being fully aware but I also do truly believe currently I’m eating healthy and not lying to myself. I’ve lost a really decent amount of weight in the past few years, I don’t lie to myself about how much I eat and in the last couple of months it’s just stalled. I’ve realised most people in the comments are US based so I’ll give both sizes I was always a uk size 18/20 or US size 14/16 and now I’m a UK size 14/16 or US size 10/12. I’m starting to wonder if my body is just incapable of being a smaller size. The main reason I ask this question is because for me to lower my currently calories I think the average calorie calculator online would deem it as “unhealthy” and too little. So I’m wondering if it’s common for people to just go into those “unhealthy” small amount of calories to lose weight but it’s not really discussed. submitted by /u/2904929492001949301 to r/NoStupidQuestions [link] [comments]
[Read more...](https://www.reddit.com/r/NoStupidQuestions/comments/178ukt2/are_slim_people_lying_about_how_much_they_eat_or/)
For a lot of my life I’ve been overweight, in the last few years I’ve lost weight but I’m definitely not slim, I’d say possibly midsize. I eat healthy and stay in suggested calories but really struggle to get to a slim weight. Are slim people lying about how much they eat and it’s an unspoken rule to eat a smaller amount or are they just blessed with a great metabolism? edits: I don’t drink my calories! I’m not a fan of really sugary drinks/coffee, even when I was at my biggest weight my coffee was black and I only really drink water. In terms of being active, I’ve walked 10,000 steps a day for the last few years. It was a promise I made to myself to keep it up and it’s something that I very rarely don’t do. The most common answer seems to be that fat people are lying to themselves which I believe somewhat to be true, I definitely was lying to myself at my biggest or maybe not even lying, just not being fully aware but I also do truly believe currently I’m eating healthy and not lying to myself. I’ve lost a really decent amount of weight in the past few years, I don’t lie to myself about how much I eat and in the last couple of months it’s just stalled. I’ve realised most people in the comments are US based so I’ll give both sizes I was always a uk size 18/20 or US size 14/16 and now I’m a UK size 14/16 or US size 10/12. I’m starting to wonder if my body is just incapable of being a smaller size. The main reason I ask this question is because for me to lower my currently calories I think the average calorie calculator online would deem it as “unhealthy” and too little. So I’m wondering if it’s common for people to just go into those “unhealthy” small amount of calories to lose weight but it’s not really discussed. submitted by /u/2904929492001949301 to r/NoStupidQuestions [link] [comments]
[Read more...](https://www.reddit.com/r/NoStupidQuestions/comments/178ukt2/are_slim_people_lying_about_how_much_they_eat_or/)
Reddit
Explore this post and more from the NoStupidQuestions community
Are slim people lying about how much they eat or are they just blessed with a good metabolism?
For a lot of my life I’ve been overweight, in the last few years I’ve lost weight but I’m definitely not slim, I’d say possibly midsize. I eat healthy and stay in suggested calories but really struggle to get to a slim weight. Are slim people lying about how much they eat and it’s an unspoken rule to eat a smaller amount or are they just blessed with a great metabolism? edits: I don’t drink my calories! I’m not a fan of really sugary drinks/coffee, even when I was at my biggest weight my coffee was black and I only really drink water. In terms of being active, I’ve walked 10,000 steps a day for the last few years. It was a promise I made to myself to keep it up and it’s something that I very rarely don’t do. The most common answer seems to be that fat people are lying to themselves which I believe somewhat to be true, I definitely was lying to myself at my biggest or maybe not even lying, just not being fully aware but I also do truly believe currently I’m eating healthy and not lying to myself. I’ve lost a really decent amount of weight in the past few years, I don’t lie to myself about how much I eat and in the last couple of months it’s just stalled. I’ve realised most people in the comments are US based so I’ll give both sizes I was always a uk size 18/20 or US size 14/16 and now I’m a UK size 14/16 or US size 10/12. I’m starting to wonder if my body is just incapable of being a smaller size. The main reason I ask this question is because for me to lower my currently calories I think the average calorie calculator online would deem it as “unhealthy” and too little. So I’m wondering if it’s common for people to just go into those “unhealthy” small amount of calories to lose weight but it’s not really discussed. submitted by /u/2904929492001949301 to r/NoStupidQuestions link comments
Read more...
For a lot of my life I’ve been overweight, in the last few years I’ve lost weight but I’m definitely not slim, I’d say possibly midsize. I eat healthy and stay in suggested calories but really struggle to get to a slim weight. Are slim people lying about how much they eat and it’s an unspoken rule to eat a smaller amount or are they just blessed with a great metabolism? edits: I don’t drink my calories! I’m not a fan of really sugary drinks/coffee, even when I was at my biggest weight my coffee was black and I only really drink water. In terms of being active, I’ve walked 10,000 steps a day for the last few years. It was a promise I made to myself to keep it up and it’s something that I very rarely don’t do. The most common answer seems to be that fat people are lying to themselves which I believe somewhat to be true, I definitely was lying to myself at my biggest or maybe not even lying, just not being fully aware but I also do truly believe currently I’m eating healthy and not lying to myself. I’ve lost a really decent amount of weight in the past few years, I don’t lie to myself about how much I eat and in the last couple of months it’s just stalled. I’ve realised most people in the comments are US based so I’ll give both sizes I was always a uk size 18/20 or US size 14/16 and now I’m a UK size 14/16 or US size 10/12. I’m starting to wonder if my body is just incapable of being a smaller size. The main reason I ask this question is because for me to lower my currently calories I think the average calorie calculator online would deem it as “unhealthy” and too little. So I’m wondering if it’s common for people to just go into those “unhealthy” small amount of calories to lose weight but it’s not really discussed. submitted by /u/2904929492001949301 to r/NoStupidQuestions link comments
Read more...
Reddit
Explore this post and more from the NoStupidQuestions community
*Entire house built in 2 hours and 45 minutes in 1983*
In 1983, there was an attempt to break the world record for fastest time to build a house from the ground up. The time to beat was 4 hours and 18 minutes, and they built the house in just over 2 hours and 45 minutes. Source. submitted by /u/ClayshRoyayshKJ to r/Damnthatsinteresting [link] [comments]
[Read more...](https://www.reddit.com/r/Damnthatsinteresting/comments/178zkzm/entire_house_built_in_2_hours_and_45_minutes_in/)
In 1983, there was an attempt to break the world record for fastest time to build a house from the ground up. The time to beat was 4 hours and 18 minutes, and they built the house in just over 2 hours and 45 minutes. Source. submitted by /u/ClayshRoyayshKJ to r/Damnthatsinteresting [link] [comments]
[Read more...](https://www.reddit.com/r/Damnthatsinteresting/comments/178zkzm/entire_house_built_in_2_hours_and_45_minutes_in/)
Reddit
From the Damnthatsinteresting community on Reddit: Entire house built in 2 hours and 45 minutes in 1983
Explore this post and more from the Damnthatsinteresting community